MedTrace Logo

Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer

NCT03263520 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-02-26

No results posted yet for this study

Summary

Compare the use of nandrolone associated with corticosteroid for the treatment of cancer-induced malnutrition to treatment with corticosteroids alone in patients with tumors in the high gastro-intestinal tract, liver, pancreas and bile ducts in palliative treatment.

Conditions

  • Cachexia; Cancer

Interventions

DRUG

Nandrolone Decanoate

Drug administration

DRUG

Dexamethasone

Drug administration

Sponsors & Collaborators

  • Hospital Erasto Gaertner

    lead OTHER

Principal Investigators

  • Vinicius B Preti, MD · Hospital Erasto Gaertner/ Liga Paranaense de Combate ao Cancer

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2017-08-30
Completion
2017-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03263520 on ClinicalTrials.gov